home
College of Arts and Sciences

Department of Psychological Science

Stacey Sigmon

Human Behavioral Pharmacology

Stacey Sigmon

Stacey Sigmon
Research Associate Professor of Psychology
Research Associate Professor of Psychiatry

Education
  • B.A. University of North Carolina at Chapel Hill, 1995
  • M.A. University of Vermont, 1999
  • Ph.D. University of Vermont, 2002
C.V. (PDF)
Email: stacey.sigmon@uvm.edu
Phone: (802) 656-8714
Room: FAHC-UHC Room 1415

Directorships
Director, The Chittenden Clinic

Duties
Faculty, Substance Abuse Treatment Center
Faculty, Human Behavioral Pharmacology Laboratory
Faculty, Behavioral Pharmacology of Drug Dependence Training Program

Areas
Behavioral and pharmacological treatment of opioid dependence; Novel formulations of pharmacotherapies for opioid dependence; Smoking cessation among opioid-dependent patients using a behavioral approach; Laboratory models for understanding the interactions between stimulant medications, including nicotine, cocaine, d-amphetamine and methylphenidate; Behavioral treatments of substance use/abuse among individuals with serious mental illness.

Facilities

Vermont Center on Behavior and Health: The Vermont Center on Behavior and Health (VCBH) is an interdisciplinary center of research excellence committed to investigating relationships between personal behavior patterns (i.e., lifestyle) and risk for chronic disease and premature death.

Human Behavioral Pharmacology Laboratory (HBPL): This facility of 6,000 sq. ft., is located adjacent to the University of Vermont (UVM) campus in Burlington and is the site for laboratory research in drug self-administration, drug discrimination, and the direct effects of drugs and for treatment studies for smoking cessation.

Substance Abuse Treatment Center (SATC): This facility of 2,900 sq. ft., is also located adjacent to the UVM campus, and is our site for the development and testing of scientifically-based behavioral and pharmacological treatments for cocaine and opioid dependence as well as smoking cessation for pregnant women. For addtional information on the Substance Abuse Treatment Center3.

Representative Publications

  • Dunn, K.E., Sigmon, S.C., Reimann, E., Heil, S.H., & Higgins, S.T. (2009). Effects of smoking cessation on illicit drug use among opioid maintenance patients. Journal of Drug Issues, Vol. 39(2), 313-328.
  • Sigmon, S.C., Herning, R.I., Better, W., Cadet, J.L., & Griffiths, R.R. (2009). Caffeine withdrawal, acute effects, tolerance, and absence of net beneficial effects of chronic administration: Cerebral blood flow velocity, quantitative EEG and subjective effects. Psychopharmacology, 204, 573-585.
  • Sigmon, S.C., Dunn, K.E., Badger, G.J., Heil, S.H., & Higgins, S.T. (2009). Brief buprenorphine detoxification for the treatment of prescription opioid dependence: A pilot study. Addictive Behaviors, 34, 304-311.
  • Dunn, K.E., Sigmon, S.C., Thomas, C.S., Heil, S.H. & Higgins, S.T. (2008). Voucher-based contingent reinforcement of smoking abstinence among methadone-maintained patients: A pilot study. Journal of Applied Behavior Analysis, 41, 527-538.
  • Dunn, K.E., Sigmon, S.C., McGee, M.R., Heil, S.H., & Higgins, S.T. (2008). Evaluation of ongoing oxycodone abuse among methadone-maintained patients. Journal of Substance Abuse Treatment, 35, 451-456.
  • Sigmon, S.C. (2006). Characterizing the emerging population of prescription opioid abusers. The American Journal on Addictions, 15 (3), 208-212.

Chair

Clinical Training Program Director

General/Experimental Program Director

Undergraduate Director

Business Manager

Biobehavioral
Clinical
Developmental
Social
Behavioral Pharmacology
Joint Appointment
Behavior Therapy and Psychotherapy Faculty
Clinical Psychology Internship Program (CPIP)
Post-Doctoral Fellows
Emeriti Faculty
Lecturers
Research/Adjunct
Contact UVM © 2014 The University of Vermont - Burlington, VT 05405 - (802) 656-3131